Flow cytometric measurement of proliferation‐associated nuclear antigen p105 and DNA content in immuno‐proliferative small intestinal disease (IPSID)

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Surgical Oncology

• Publication date

  1995-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jso.2930580106PMID 7529850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Image analysis confirmation of DNA aneuploidy in flow cytometric DNA distributions having a wide coefficient of variation of the G0/G1 peak.

  1990cited by this paper
• Immunoproliferative small intestinal disease: portrait of a potentially preventable cancer from the Third World.

  1990cited by this paper
• Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas.

  1989influential reference
• Modulation of the nuclear antigen p105 as a function of cell‐cycle progression

  1987cited by this paper
• The design and analysis of clinical experiments

  1987cited by this paper
• Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomas.

  1986cited by this paper
• Simultaneous nuclear antigen and DNA content quantitation using paraffin-embedded colonic tissue and multiparameter flow cytometry.

  1986cited by this paper
• Cell proliferation and DNA content in non‐hodgkin' s lymphoma: Flow cytometry in relation to lymphoma classification

  1986cited by this paper
• Alpha-heavy chain disease.

  1986cited by this paper
• Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas.

  1986cited by this paper
• Middle Eastern intestinal lymphoma.

  1985cited by this paper
• Prognostic significance of DNA‐analysis by flow cytometry in non‐Hodgkin's lymphoma

  1985cited by this paper
• Identification of a nuclear protein component of interchromatin granules using a monoclonal antibody and immunogold electron microscopy.

  1984cited by this paper
• Use of immunogold electron microscopy and monoclonal antibodies in the identification of nuclear substructures.

  1984cited by this paper
• Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

  1983cited by this paper
• Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

  1982cited by this paper
• Lymphomas involving the gastrointestinal tract.

  1982cited by this paper
• Lymphomas involving the gastrointestinal tract

  1982cited by this paper
• Labeling index as a prognostic marker in non-Hodgkin's lymphomas.

  1981cited by this paper
• Primary small intestinal lymphomas and alpha-heavy-chain disease. A study of 43 cases from a pathology department in Israel.

  1979cited by this paper
• Alpha-chain disease--a report of eleven patients from Iran.

  1979cited by this paper
• Natural history of alpha-chain disease and the so-called Mediterranean lymphoma.

  1978cited by this paper
• New presentation of alpha heavy chain disease: North American polypoid gastrointestinal lymphoma. Clinical and cellular studies

  1978cited by this paper
• Alpha heavy chain disease (report of 18 cases from Iraq).

  1978cited by this paper
• Alpha-chain disease. Mediterranean lymphoma and primary intestinal lymphoma in Western countries: a review of the cases in the literature.

  1977cited by this paper
• Immunobiology and pathogenesis of alpha chain disease.

  1977cited by this paper
• Immunochemical, clical, and pathological features of alpha-chain disease.

  1975cited by this paper
• Alpha chain disease clinicopathological features and relationship to so-called Mediterranean lymphoma.

  1975cited by this paper
• Immunochemical, Clinical, and Pathological Features of a-Chain Disease

  1975cited by this paper
• The pathology of so‐called mediterranean abdominal lymphoma with malabsorption

  1972cited by this paper
• Alpha-Chain Disease: A New Immunoglobulin Abnormality

  1968cited by this paper
• Cancer in Lebanon and the near east

  1962cited by this paper

• Immunoproliferative small intestinal disease: current concepts.

  2005cites this paper
• Heavy chain diseases.

  2005cites this paper
• P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003.

  2003cites this paper
• Heavy chain disease

  2002cites this paper
• Primary low-grade lymphomas of the intestine. Case 1: immunoproliferative small intestinal disease.

  1999cites this paper
• α-heavy chain disease, Mediterranean lymphoma, and immunoproliferative small intestinal disease

  1999cites this paper
• α-heavy chain disease, Mediterranean lymphoma, and immunoproliferative small intestinal disease: A review of clinicopathological features, pathogenesis, and differential diagnosis

  1999cites this paper
• Alpha-heavy chain disease, Mediterranean lymphoma, and immunoproliferative small intestinal disease: a review of clinicopathological features, pathogenesis, and differential diagnosis.

  1999cites this paper